The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
BDDCS, the Rule of 5 and drugability
Open accessAbstract
The rule of 5 methodology appears to be as useful today in defining drugability as when it was proposed, but recognizing that the database that we used includes only drugs that successfully reached the market. We do not view additional criteria necessary nor did we find significant deficiencies in the four Rule of 5 criteria originally proposed by Lipinski and coworkers. BDDCS builds upon the Rule of 5 and can quite successfully predict drug disposition characteristics for drugs both meeting and not meeting Rule of 5 criteria. More recent expansions of classification systems have been proposed and do provide useful qualitative and quantitative predictions for clearance relationships. However, the broad range of applicability of BDDCS beyond just clearance predictions gives a great deal of further usefulness for the combined Rule of 5/BDDCS system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citationAn analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationImpact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
Wacher, V. J., Wu, C., & Benet, L. Z. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130302 · Cited by 857
Self-citation(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Property distribution of drug-related chemical databases*
Oprea, T. I. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008130001697 · Cited by 628
Self-citationBDDCS Applied to Over 900 Drugs
Benet, L. Z., Broccatelli, F., & Oprea, T. I. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9290-9 · Cited by 626
Self-citationThe Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438
Self-citationCustodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
Self-citationRole of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Wu, C.-Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., & Wacher, V. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90168-x · Cited by 356
Self-citationBenet, L. Z. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23359 · Cited by 342
Self-citationPredicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Varma, M. V., Steyn, S. J., Allerton, C., & El-Kattan, A. F. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1749-4 · Cited by 334
Effects of renal failure on drug transport and metabolism
Sun, H., Frassetto, L., & Benet, L. Z. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.010 · Cited by 290
Self-citationUnmasking the Dynamic Interplay between Intestinal P-Glycoprotein and CYP3A4
Cummins, C. L., Jacobsen, W., & Benet, L. Z. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1036 · Cited by 289
Self-citationUnmasking the dynamic interplay between efflux transporters and metabolic enzymes
Benet, L. Z., Cummins, C. L., & Wu, C. Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2002.12.002 · Cited by 256
Self-citationSLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin
NIEMI, M., PASANEN, M., & NEUVONEN, P. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.06.010 · Cited by 250
Benet, L., Cummins, C., & Wu, C. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489389 · Cited by 188
Self-citationMolecular inflation, attrition and the rule of five
Leeson, P. D. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.018 · Cited by 179
Cummins, C. L., Wu, C., & Benet, L. Z. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128388 · Cited by 166
Self-citationCummins, C. L., Salphati, L., Reid, M. J., & Benet, L. Z. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044719 · Cited by 161
Self-citationThe Use of BDDCS in Classifying the Permeability of Marketed Drugs
Benet, L. Z., Amidon, G. L., Barends, D. M., Lennernäs, H., Polli, J. E., Shah, V. P., Stavchansky, S. A., & Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9523-x · Cited by 147
Self-citationEFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN
Sun, H. L., Huang, Y., Frassetto, L. A., & Benet, L. Z. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000521 · Cited by 128
Self-citationYang, X., Gandhi, Y., Duignan, D. B., & Morris, M. E. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9124-1 · Cited by 126
Lau, Y. Y., Wu, C., Okochi, H., & Benet, L. Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061770 · Cited by 110
Self-citationCummins, C. L., Jacobsen, W., Christians, U., & Benet, L. Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058065 · Cited by 108
Self-citationEco-directed sustainable prescribing: feasibility for reducing water contamination by drugs
Daughton, C. G. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.06.013 · Cited by 103
Cummins, C. L., Mangravite, L. M., & Benet, L. Z. (2001) · Pharmaceutical Research · doi:10.1023/a:1010914624111 · Cited by 94
Self-citationBDDCS Class Prediction for New Molecular Entities
Broccatelli, F., Cruciani, G., Benet, L. Z., & Oprea, T. I. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2004302 · Cited by 88
Self-citationThe Remarkable Transport Mechanism of P-Glycoprotein: A Multidrug Transporter
Al‐Shawi, M. K., & Omote, H. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-9497-5 · Cited by 79
Improving the prediction of the brain disposition for orally administered drugs using BDDCS
Broccatelli, F., Larregieu, C. A., Cruciani, G., Oprea, T. I., & Benet, L. Z. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.008 · Cited by 78
Self-citationHosey, C. M., Chan, R., & Benet, L. Z. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9845-2 · Cited by 77
Self-citationCamenisch, G., & Umehara, K. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1784 · Cited by 76
Sun, H., Frassetto, L. A., Huang, Y. L., & Benet, L. Z. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.247 · Cited by 67
Self-citationWu, C., & Benet, L. Z. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1292 · Cited by 63
Self-citationReyes, M., & Benet, L. Z. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22640 · Cited by 51
Self-citationGarrison, K. L., Şahin, S., & Benet, L. Z. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24505 · Cited by 49
Self-citationPredicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans
Hosey, C. M., Broccatelli, F., & Benet, L. Z. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9636-1 · Cited by 41
Self-citationBroccatelli, F., Mannhold, R., Moriconi, A., Giuli, S., & Carosati, E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300156r · Cited by 40
In Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical Parameters
Kusama, M., Toshimoto, K., Maeda, K., Hirai, Y., Imai, S., Chiba, K., Akiyama, Y., & Sugiyama, Y. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032789 · Cited by 39
Vuppalanchi, R., Gotur, R., Reddy, K. R., Fontana, R. J., Ghabril, M., Kosinski, A. S., Gu, J., Serrano, J., & Chalasani, N. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.12.016 · Cited by 36
The extended clearance model and its use for the interpretation of hepatobiliary elimination data
Camenisch, G., Riede, J., Kunze, A., Huwyler, J., Poller, B., & Umehara, K. (2015) · ADMET & DMPK · doi:10.5599/admet.3.1.144 · Cited by 32
Storstein, L. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975173313 · Cited by 32
Kunze, A., Poller, B., Huwyler, J., & Camenisch, G. (2015) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmdi-2015-0003 · Cited by 32
Zheng, Y., Chen, X., & Benet, L. Z. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0310-2 · Cited by 29
Self-citationToshimoto, K., Wakayama, N., Kusama, M., Maeda, K., Sugiyama, Y., & Akiyama, Y. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057893 · Cited by 29
Rifaximin for the treatment of acute infectious diarrhea
Hong, K. S., & Kim, J. S. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11398734 · Cited by 27
Hosey, C. M., & Benet, L. Z. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500783g · Cited by 26
Self-citationSwift, B., Tian, X., & Brouwer, K. L. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9909-z · Cited by 18
Chan, R., Wei, C.-Y., Chen, Y.-T., & Benet, L. Z. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9898-x · Cited by 16
Self-citation
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Tallei, T. E., Tumilaar, S. G., Niode, N. J., Fatimawali, Kepel, B. J., Idroes, R., Effendi, Y., Sakib, S. A., & Emran, T. B. (2020) · Scientifica · doi:10.1155/2020/6307457 · Cited by 293
Artificial Intelligence for Drug Discovery: Are We There Yet?
Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236
“It is undeniable that Ro5 criteria have had a significant impact on medicinal chemistry (180).”
BackgroundSelf-citationEladl, O. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117297 · Cited by 44
Metadata
- Authors
- Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 101
- Pages
- 89-98
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2379628571
- Cited by
- 892
- References
- 54
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.